• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童反复感染的临床特征及危险因素分析

Analysis of clinical characteristics and risk factors of recurrent infection in children.

作者信息

Huang Jin-Yue, Wang Ning, Wang Jing-Yao, Zuo Hua-Chu, Li Juan, Zhao Yu

机构信息

Tianjin Pediatric Research Institute, Tianjin Key Laboratory of Birth Defects for Prevention and Treatment, Tianjin Children's Hospital (Children's Hospital of Tianjin University), Tianjin, China.

Department of Gastroenterology, Tianjin Children's Hospital (Children's Hospital of Tianjin University), Tianjin, China.

出版信息

Front Pediatr. 2025 Jul 18;13:1571199. doi: 10.3389/fped.2025.1571199. eCollection 2025.

DOI:10.3389/fped.2025.1571199
PMID:40755912
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12313556/
Abstract

OBJECTIVE

To analyze clinical characteristics and risk factors for recurrence of infection (CDI) in children.

METHODS

Clinical data were retrospectively collected from all children (<18 years) hospitalized with CDI at Tianjin Children's Hospital between September 2018 and December 2023.

RESULTS

In total, 115 patients (66 males and 49 females;) were divided into recurrence ( = 38) and non-recurrence ( = 77) groups. Logistic regression was used to compare clinical data and analyze risk factors for CDI recurrence. The recurrent CDI(rCDI) and non-recurrence groups had statistically significant differences in terms of age, comorbidities, prior antibiotic exposure, mode of CDI acquisition (hospital vs. community), colonoscopy(the rationale for colonoscopy data inclusion-diagnosis confirmation or ruling out other causes), treatment selection, levels of interleukin-6 and creatine kinase, and body mass index ( < 0.05). Multivariate analysis showed that healthcare-associated CDI [odds ratio [OR] = 14.754, 95% confidence interval []:4.568-47.650,  = 0.000] is an independent risk factor for CDI recurrence in children ( < 0.05), with sensitivity and specificity of 73.7% and 87.0%, respectively.

CONCLUSION

Healthcare-associated CDI (HA-CDI)is an independent risk factor for pediatric rCDI, and the introduction of this indicator in diagnosis has certain accuracy in predicting rCDI.

摘要

目的

分析儿童艰难梭菌感染(CDI)的临床特征及复发的危险因素。

方法

回顾性收集2018年9月至2023年12月期间在天津市儿童医院住院的所有CDI患儿(<18岁)的临床资料。

结果

共115例患者(男66例,女49例)分为复发组(n = 38)和非复发组(n = 77)。采用Logistic回归比较临床资料并分析CDI复发的危险因素。复发性CDI(rCDI)组和非复发组在年龄、合并症、既往抗生素暴露史、CDI获得方式(医院获得性与社区获得性)、结肠镜检查(纳入结肠镜检查数据的理由——确诊或排除其他病因)、治疗选择、白细胞介素-6和肌酸激酶水平以及体重指数方面存在统计学显著差异(P < 0.05)。多因素分析显示,医疗保健相关CDI[比值比(OR)= 14.754,95%置信区间(CI):4.568 - 47.650,P = 0.000]是儿童CDI复发的独立危险因素(P < 0.05),其敏感度和特异度分别为73.7%和87.0%。

结论

医疗保健相关CDI(HA-CDI)是儿童rCDI的独立危险因素,将该指标纳入诊断对预测rCDI具有一定准确性。

相似文献

1
Analysis of clinical characteristics and risk factors of recurrent infection in children.儿童反复感染的临床特征及危险因素分析
Front Pediatr. 2025 Jul 18;13:1571199. doi: 10.3389/fped.2025.1571199. eCollection 2025.
2
Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile).粪便微生物移植治疗复发性艰难梭菌(艰难梭菌)。
Cochrane Database Syst Rev. 2023 Apr 25;4(4):CD013871. doi: 10.1002/14651858.CD013871.pub2.
3
Real-world use of bezlotoxumab to prevent recurrent infections: a single-center experience and meta-analysis.贝佐妥单抗预防反复感染的真实世界应用:单中心经验及荟萃分析
Therap Adv Gastroenterol. 2025 Jun 21;18:17562848251346593. doi: 10.1177/17562848251346593. eCollection 2025.
4
Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults.成人艰难梭菌相关性腹泻的抗生素治疗
Cochrane Database Syst Rev. 2017 Mar 3;3(3):CD004610. doi: 10.1002/14651858.CD004610.pub5.
5
Recurrent Clostridioides difficile Infection (CDI) in Patients Treated With Vancomycin at Johns Hopkins Aramco Healthcare (JHAH), Dhahran, Saudi Arabia.沙特阿拉伯达兰市约翰霍普金斯阿美医疗保健公司(JHAH)接受万古霉素治疗的患者复发性艰难梭菌感染(CDI)
Cureus. 2025 May 31;17(5):e85116. doi: 10.7759/cureus.85116. eCollection 2025 May.
6
Clinical significance of toxin EIA positivity in patients with suspected infection: systematic review and meta-analysis.疑似感染患者毒素酶免疫测定阳性的临床意义:系统评价与Meta分析
J Clin Microbiol. 2025 Jan 31;63(1):e0097724. doi: 10.1128/jcm.00977-24. Epub 2024 Dec 12.
7
Association of Gastric Acid Suppression With Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis.胃酸抑制与艰难梭菌反复感染的关联:一项系统评价和荟萃分析。
JAMA Intern Med. 2017 Jun 1;177(6):784-791. doi: 10.1001/jamainternmed.2017.0212.
8
Oral Vancomycin for Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial.口服万古霉素预防艰难梭菌反复感染:一项随机临床试验
JAMA Netw Open. 2025 Jul 1;8(7):e2517834. doi: 10.1001/jamanetworkopen.2025.17834.
9
Treatment outcomes of mild to moderate Clostridioides difficile infection in inflammatory bowel disease: an Australian experience.炎症性肠病中轻至中度艰难梭菌感染的治疗结果:澳大利亚的经验
Intern Med J. 2024 Dec;54(12):2009-2014. doi: 10.1111/imj.16545. Epub 2024 Oct 18.
10
Clostridioides difficile co-infection worsens prognosis in inflammatory bowel disease in patients with cytomegalovirus colitis.艰难梭菌合并感染会使巨细胞病毒性结肠炎患者的炎症性肠病预后恶化。
Int J Colorectal Dis. 2025 Jul 23;40(1):161. doi: 10.1007/s00384-025-04954-2.

本文引用的文献

1
Faecal microbiota transplantation in children: A systematic review.粪便微生物群移植在儿童中的应用:系统评价。
Acta Paediatr. 2024 Sep;113(9):1991-2002. doi: 10.1111/apa.17167. Epub 2024 Feb 23.
2
Characterization of Healthcare-Associated and Community-Associated Clostridioides difficile Infections among Adults, Canada, 2015-2019.加拿大 2015-2019 年成人相关医疗保健和社区获得性艰难梭菌感染的特征
Emerg Infect Dis. 2022 Jun;28(6):1128-1136. doi: 10.3201/eid2806.212262. Epub 2022 Apr 26.
3
Challenges in the Diagnosis and Management of Recurrent and Severe Clostridioides difficile Infection in Children.
儿童复发性和重度艰难梭菌感染的诊断与管理挑战。
J Pediatric Infect Dis Soc. 2021 Nov 17;10(Supplement_3):S27-S33. doi: 10.1093/jpids/piab079.
4
Two-step Testing for Clostridioides Difficile is Inadequate in Differentiating Infection From Colonization in Children.两步法检测艰难梭菌在区分儿童感染与定植方面并不充分。
J Pediatr Gastroenterol Nutr. 2021 Mar 1;72(3):378-383. doi: 10.1097/MPG.0000000000002944.
5
Systemic Inflammatory Mediators Are Effective Biomarkers for Predicting Adverse Outcomes in Clostridioides difficile Infection.系统炎症介质是预测艰难梭菌感染不良结局的有效生物标志物。
mBio. 2020 May 5;11(3):e00180-20. doi: 10.1128/mBio.00180-20.
6
Clostridium difficile: A Frequent Infection in Children After Intestinal Transplantation.艰难梭菌:肠移植后儿童常见的感染。
Transplantation. 2020 Jan;104(1):197-200. doi: 10.1097/TP.0000000000002795.
7
Risk factors for community-associated Clostridioides difficile infection in young children.儿童社区相关性艰难梭菌感染的危险因素。
Epidemiol Infect. 2019 Jan;147:e172. doi: 10.1017/S0950268819000372.
8
Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children: A Joint Position Paper From the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition.粪便微生物移植治疗儿童复发性艰难梭菌感染和其他疾病:北美儿童胃肠病学、肝病学和营养学学会与欧洲儿童胃肠病学、肝病学和营养学学会联合立场文件。
J Pediatr Gastroenterol Nutr. 2019 Jan;68(1):130-143. doi: 10.1097/MPG.0000000000002205.
9
Trends and Predictors of Clostridium difficile Infection among Children: A Canadian Population-Based Study.儿童艰难梭菌感染的趋势和预测因素:一项加拿大基于人群的研究。
J Pediatr. 2019 Mar;206:20-25. doi: 10.1016/j.jpeds.2018.10.041. Epub 2018 Nov 15.
10
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).临床实践指南:成人和儿童艰难梭菌感染:美国传染病学会(IDSA)和美国医疗保健流行病学学会(SHEA) 2017 年更新。
Clin Infect Dis. 2018 Mar 19;66(7):e1-e48. doi: 10.1093/cid/cix1085.